Peptron

087010.KQ

214.45 USD

1.27

+0.60%

Overview

Last close

214.45 usd

Market cap

3.29B usd

52 week high

255.17 usd

52 week low

18.63 usd

Target price

24.55 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1282.3059

Price/Book Value

48.471

Enterprise Value

4.83B usd

EV/Revenue

1330.3124

EV/EBITDA

-17.5233

Key financials

Revenue TTM

4.08M usd

Gross Profit TTM

3.13M usd

EBITDA TTM

-7.53M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

119.66M usd

Net debt

6.04M usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.